Membership Biographical Information
Xu Luo, PhD
Aberrant suppression of apoptosis contributes to oncogenic transformation and resistance to therapeutic treatments. We are interested in the regulation of mitochondria-dependent apoptotic pathway by the Bcl-2 family proteins. Our goal is to uncover the molecular mechanisms of apoptosis and provide insights into the design of therapeutic drugs against cancer.